Frontiers in Neuroscience, 2021 · DOI: 10.3389/fnins.2021.630633 · Published: February 1, 2021
Central nerve injuries often lead to permanent disabilities because the damaged nerve fibers, called axons, don't regrow well. This review explores how non-coding RNAs, particularly lncRNA, miRNA, and circRNA, might help. Non-coding RNAs are molecules that don't code for proteins but can control gene expression. Research suggests they play a key role in nerve regeneration after injuries like spinal cord injury and optic nerve injury. By understanding how these non-coding RNAs work and interact, scientists hope to develop new therapies to promote axon regeneration and restore function after CNS injuries.
Non-coding RNAs may serve as therapeutic targets for promoting axon regeneration after CNS injuries, such as spinal cord injury and optic nerve injury.
Patient-derived cells could be reprogrammed into neurons for drug discovery related to nerve regeneration.
Non-invasive approaches for delivering non-coding RNAs, such as miRNA mimics or inhibitors through oral or intravenous injection, are becoming more available and safer.